Overview

A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the comparative efficacy of artesunate plus sulfamethoxypyrazine-pyrimethamine versus Praziquantel in the treatment of school children infected with S.mansoni in western Kenya.
Phase:
Phase 3
Details
Lead Sponsor:
Kenya Medical Research Institute
Collaborator:
Dafra Pharma
Treatments:
Artemisinins
Artesunate
Praziquantel
Pyrimethamine
Sulfalene